Hippee Health Secures Tens of Millions in Pre-A Funding to Advance Smart Home Healthcare Solutions

VCBeat (WeChat ID: vcbeat) learned at the earliest opportunity that recently,Tianjin Guoshi Technology Co., Ltd. (hereinafter referred to as “Guoshi Health”) announced the completion of its Pre-A financing round, raising tens of millions of RMB. The round was led by Fosun Health and Challenger Venture Capital, with Jinpu Disu participating as a co-investor.The funds will be primarily used for product research and development, marketing, and channel expansion.

Guoshi Health was established in 2016, dedicated to building a future-oriented home health service management platform through the Internet of Things (IoT), big data, and AI, thereby creating an “H-IoT + Health Management” model. Specifically, the company uses hardware products as its core to reach users, and then leverages these products to connect data and services, providing comprehensive health solutions tailored to home usage scenarios.

To date, Guoshi Health has built a comprehensive team covering product development, data middle platform, supply chain management, biochemical testing, and market operations. The company has been recognized as a National High-Tech Enterprise and holds more than 50 invention patents. In recent years, its innovative products have won prestigious awards, including the iF International Design Award, the Ministry of Industry and Information Technology’s “Metis” Award, the Shangge Award, and the Inspur Product Award. Guoshi Health has established partnerships with leading organizations such as Ali Health, JD Health, Fosun Health, Huawei Health, Panasonic, Xiaomi Youpin, NetEase Yanxuan, and Tongrentang.

Regarding this round of financing, He Xin, co-founder of Guoshi Health, stated:“We are deeply grateful to the investors for their recognition of our company. Over the past few years, we have not only gained widespread acknowledgment for our product innovation capabilities, but also built a more mature and comprehensive team, laying a solid foundation for the company’s future growth. We believe that following this round of financing, we will enter a fast track of rapid development, leveraging our products and services to help more users improve their health.”

Regarding the investment in Guoshi Health, Shen Han, Vice President and Chief Investment Officer (CIO) of Fosun Health, stated:“Fosun Health’s participation in Guoshi Health’s financing round will fully leverage Guoshi Health’s strengths in its smart hardware product line, particularly in the R&D, design, and manufacturing of medical-grade devices. By integrating these capabilities with Fosun Health’s chronic disease management and specialty care services, we aim to establish a new product model encompassing ‘smart hardware + services,’ ‘smart hardware + insurance,’ and ‘smart hardware + pharmaceuticals,’ covering the continuum from early screening to chronic disease management. Furthermore, in future collaborative IoT product development, Fosun Health will work with Guoshi Health to co-develop smart hardware tailored to home-based health management scenarios, exploring an ‘FC2M strategy-driven product + service innovation’ model.”

Kang Di of Challenger Venture Capital stated:“Challenger Capital is optimistic about the prospects for miniaturizing chronic disease medical devices and adapting them for home use. Guoshi Health has been deeply engaged in this area for many years, achieving significant success. Following the investment, Challenger Capital will collaborate closely with Guoshi Health in brand operations and overseas market expansion.”

Zhu Shuyan, Vice President of Investment at Jinpu Disu, stated:“With the advancement and maturation of technologies such as big data, artificial intelligence, and integrated circuits, products are now endowed with capabilities ranging from data acquisition, transmission, analysis, and storage to result visualization. This aligns with current user habits and trends favoring convenient mobile-based operation of various products, indicating that smart health products hold immense market potential. Guoshi Health is dedicated to building an H-IoT (Health Internet of Things) platform. All product development undergoes rigorous scientific validation, centering on user needs and leveraging continuous technological innovation to create portable, easy-to-use smart health devices for home use. Whether it is the smart urinalysis device, HiPee posture corrector, smart steam eye mask, or fat-burning assistant, these products demonstrate the company’s robust technological innovation and product development capabilities, as well as its profound market insight. JP Daisu will assist the company in further advancing market communication and brand building, aiming to rapidly establish it as a leading domestic brand in smart health products and deliver high-quality products to more users.”

Driven by population aging, the rising prevalence of chronic diseases among younger demographics, heightened health consumption awareness, and transformations in healthcare service models, health demands centered on households and individuals are poised for rapid growth in the future, presenting significant market opportunities for smart home medical and health products.

On one hand, certain medical-grade products will become standard household items, evolving toward miniaturization, intelligence, data integration, aesthetic appeal, and a greater emphasis on user experience. On the other hand, improvements in the consumer environment are driving consumer-grade health products toward greater professionalism, medical scientific rigor, and trendiness.

There is a growing trend toward the convergence of medical-grade and consumer-grade products, creating more opportunities for innovative brands. Guoshi Health has decisively entered the field of home smart medical health products, establishing the Guoshi Health brand in 2016 with a commitment to the research and development of home healthcare devices.

Closely aligned with family needs scenarios, the company has launchedMedical-grade products such as smart urinalysis devices, 24-hour ambulatory ECG monitors, and transcranial microcurrent stimulators; also launchedSmart Posture Correction Elf, Smart Steam Eye Mask, Smart Pillbox, Smart Fat-Burning Elf, and other consumer health products。

Source: Guoshi Health

Among them,Guoshi Health launched its first medical-grade product, the Smart Health Elf, in 2018., is a home-use portable urinalysis device, sized like a pen. The product underwent three years of research and development, with over 8,000 comparative tests conducted in collaboration with the Department of Laboratory Medicine at PLA General Hospital (301 Hospital), resulting in clinical laboratory reports and obtaining the National Class II Medical Device Registration Certificate.

Functionally, the product features built-in high-precision sensors that enable one-touch measurement of 14 urinalysis indicators through a non-invasive, painless, and zero-contact method. It also integrates with intelligent mobile analysis, allowing users to monitor their health status at any time. Furthermore, Guoshi Health has collaborated with Panasonic to develop a new generation of smart toilet seats for general wellness, adding urinalysis capabilities to conventional toilets.

The Most Representative Smart Posture Correction Device in Consumer Health Products, in response to the growing demand for spinal health solutions, the product features a non-intrusive wearable design that keeps its intelligent detection module snugly against the neck. This enables real-time posture monitoring and alerts, prompting users to proactively adjust their posture. Additionally, the product offers daily posture correction analysis, professional posture correction courses certified by the General Administration of Sport of China, and a variety of motion-sensing games to enhance engagement and interactivity.

Source: Fruit Health

The philosophy of Fruit Health is “preventing disease before it occurs and preventing progression after onset.”Future health management will shift upstream from treatment, placing greater emphasis on early prevention and intervention, with the home emerging as a key setting. In light of this, the company is focusing on its H-IoT product strategy, leveraging smart medical and health products to enter consumer home-use scenarios.

In the future, Guoshi Health will prioritize intelligence, data-driven solutions, aesthetic design, and superior user experience in its strategic layout of home healthcare product lines. Particularly in high-demand key areas, it will introduce innovative product forms and cost-effective smart health products.

Fosun Health is a controlled subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Codes: 600196.SH, 02196.HK). Upholding Fosun Pharma Group’s mission to “bring greater happiness to families worldwide,” Fosun Health gains deep insights into the health needs of family users, fully leverages Fosun Pharma Group’s core strengths in healthcare, pharmaceuticals, insurance, and consumer health within the broader health industry, drives industrial interconnectivity through cutting-edge technological innovation in digital healthcare, integrates the entire healthcare value chain, and builds an omni-scenario health ecosystem featuring seamless online-offline integration based on the C2M (Consumer-to-Manufacturer) model.

Fosun Health is committed to providing family users with medical-grade, one-stop, full-lifecycle health management and specialized specialty solutions, building a comprehensive smart healthcare service system encompassing “medical care, pharmaceuticals, insurance, and wellness,” so that every family has its own intelligent health record. Adhering to the values of “Caring for Life, Customer First, Pursuit of Excellence, and Innovation and Openness,” Fosun Health takes “Making Families Healthier and Lives Better” as its mission, continuously improving quality of life and leading the upgrade toward greater well-being.

Challenger Venture Capital, founded in 2014 by Tang Binsen, the founder of Elex, focuses on investments in the consumer sector and TMT (Technology, Media, and Telecommunications), with cumulative assets under management reaching RMB 10 billion. Adhering to its core philosophy of “Chinese Innovation, Challenging Giants, Investing in Quality Products, and Believing in Young Talent,” Challenger Venture Capital remains committed to its mission of investing in outstanding ventures.

Since its inception, Challenger Ventures has cumulatively invested in over 100 startups, with portfolio companies including Tiger Brokers (NASDAQ: TIGR), Home Interactive (03798.HK), Shanghai Mutong (acquired by ByteDance), Genki Forest, Huoli 28, Panzi Woman’s Studio, BIGOFFS, M Stand, Ma Ji Yong, and MiniJ Technology. Deeply entrenched in the consumer sector, Challenger has also garnered numerous industry accolades, such as Zero2IPO Group’s “Top 30 Early-Stage Investment Firms in China for 2020” and “Top 30 Investment Firms in China’s Cultural Consumption Sector for 2020.”

Jinpu Disu Capital is a private equity fund management company jointly established by Jinpu Investment and Dazzle Fashion (603587.SH). Its professional equity investment funds focus on the full-lifecycle emerging consumption sector, centered on “Better Life” and technology-enabled innovation. Advocating value investing, it is committed to co-creation and win-win outcomes with ecosystem partners.